Drug
Keppra
Keppra: highest development phase Phase 3, developed by UCB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- UCB
Trials
| Drug | Phase | Indication |
|---|---|---|
| Keppra XR (Levetiracetam XR) NCT00419393 | Phase 3 | Epilepsy |
Latest
No recent events.
Follow Keppra on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.